Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database-Reference-Cited by-同舟云学术

Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database

Published:2015-08 Issue:4 Volume:39 Page:593-599
ISSN:1877-7821
Container-title:Cancer Epidemiology
language:en
Short-container-title:Cancer Epidemiology

Author:

Duchman Kyle R.,Gao Yubo,Miller Benjamin J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Epidemiology

Reference34 articles.

1. Osteosarcoma: improvement in survival limited to high-grade patients only;Jawad;J Cancer Res Clinc Oncol,2011

2. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program;Mirabello;Cancer,2009

3. Doxorubicin in disseminated osteosarcoma;Cortes;JAMA,1972

4. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy;Jaffe;Cancer,1973

5. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols;Bielack;J Clin Oncol,2002

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Social Determinants of Health on the Prognosis of Primary Bone Tumors;JBJS Reviews;2024-09

2. Exploring Pediatric Vertebral, Sacral, and Pelvic Osteosarcomas through the NCDB: Demographics, Treatment Utilization, and Survival Outcomes;Children;2024-08-21

3. Statistics of bone sarcoma in Japan: report from the population-based cancer registry in Japan;International Journal of Clinical Oncology;2024-06-11

4. Intrinsic Epigenetic State of Primary Osteosarcoma Drives Metastasis;Molecular Cancer Research;2024-06-06

5. The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas;Frontiers in Immunology;2024-05-03